omega-n-methylarginine has been researched along with s 20928 in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (s 20928) | Trials (s 20928) | Recent Studies (post-2010) (s 20928) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 17 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delagrange, P; O'Rourke, ST; Scalbert, E; Vanhoutte, PM; Yang, Q | 1 |
1 other study(ies) available for omega-n-methylarginine and s 20928
Article | Year |
---|---|
Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Vessels; Drug Synergism; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Melatonin; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Serotonin; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2001 |